Larimar Therapeutics, Inc. - LRMR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 02, 2026 | SCHEDULE 13D/A | — | 10.25% | 103,590,392 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Rajeev Shah | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Blue Owl Capital Holdings LP | 9.99% | 8,464,663 | View |
| Nov 06, 2025 | SCHEDULE 13G/A | Millennium Management LLC | 5.8% | 4,966,831 | View |
| Nov 06, 2025 | SCHEDULE 13G/A | Millennium Group Management LLC | 5.8% | 4,966,831 | View |
| Nov 06, 2025 | SCHEDULE 13G/A | Israel A. Englander | 5.8% | 4,966,831 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.